8 Results

People

  1. Dusza
    Dusza
  2. Geller
    Geller
  3. Gordon
    Gordon
  4. Kuo
    Kuo
  5. Lavin
    Lavin
  6. Lezcano Lopez
    Lezcano Lopez
  7. Markova
    Markova
  8. Pulitzer
    Pulitzer
  9. Stuver
    Stuver
  10. Chapman
    Chapman

Groups

  1. Dermatology Service (8)
  2. Department of Medicine (6)
  3. Dermatology (6)
  4. Division of Subspecialty Medicine (6)
  5. Department of Pathology and Laboratory Medicine (5)
  6. GME, Medicine (4)
  7. Graduate Medical Education (4)
  8. Sloan Kettering Institute Postdocs (4)
  9. Survivorship Research (4)
  10. Melanoma Disease Management Team (3)
  1. "dupilumab"
Formats
  1. Journal Article (3)
  2. Research Letter (3)
  3. Editorial (1)
  4. Review (1)
Groups
  1. Dermatology Service (8)
  2. Department of Medicine (6)
  3. Dermatology (6)
  4. Division of Subspecialty Medicine (6)
  5. Department of Pathology and Laboratory Medicine (5)
  6. GME, Medicine (4)

More Groups

People
  1. Alina Markova (4)
  2. Allison Gordon (3)
  3. Shamir Geller (3)
  4. Stephen Dusza (3)
  5. Alyce Kuo (2)
  6. Leore Lavin (2)

More People

Years
  1. 2025 (4)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (1)
Publications
  1. JAAD Case Reports (1)
  2. Journal for ImmunoTherapy of Cancer (1)
  3. Journal of Allergy and Clinical Immunology: In Practice (1)
  4. Journal of Investigative Dermatology (1)
  5. Journal of the American Academy of Dermatology (1)
  6. Journal of the European Academy of Dermatology and Venereology (1)

More Publications

Publishers
  1. Biomed Central Ltd (1)
  2. Elsevier B.V. (1)
  3. Elsevier Inc. (1)
  4. Elsevier Science, Inc. (1)
  5. MDPI (1)
  6. Mosby Elsevier (1)

More Publishers

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnosis of cutaneous T-cell lymphoma following exposure to biologic agents for atopic dermatitis: A retrospective cohort study from a single tertiary cancer center
    Journal Article

    Liao, V.; Lavin, L.; Pulitzer, M. P.; Stuver, R.; Geller, S.
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma and dupilumab use: A retrospective matched cohort study of clinical characteristics and treatment outcomes
    Research Letter

    Stuver, R.; Dusza, S.; Epstein-Peterson, Z. D.; Ghione, P.; Horwitz, S. M.; Johnson, W.; Moskowitz, A. J.; Myskowski, P.; Pulitzer, M.; Geller, S.
    Journal of the European Academy of Dermatology and Venereology (2025)

    Fulltext@MSK | Save
  • Use of dupilumab to manage a grade 3 cutaneous adverse effect from enfortumab vedotin/pembrolizumab treatment in a patient with metastatic urothelial carcinoma
    Journal Article

    Gillis, M. C.; Weir, V. R.; Lezcano, C.; Iyer, G.; Gordon, A.
    JAAD Case Reports (2025)

    Fulltext@MSK | Save
  • Cutaneous T-cell lymphoma after dupilumab use: A real-world pharmacovigilance study of the FDA adverse event reporting system
    Research Letter

    Lavin, L.; Dusza, S.; Geller, S.
    Journal of Investigative Dermatology (2025)

    Fulltext@MSK | Save
  • Cutaneous hypersensitivity reactions to immune checkpoint inhibitors
    Editorial

    Storgard, R.; Markova, A.
    Journal of Allergy and Clinical Immunology: In Practice (2024)

    Fulltext@MSK | Save
  • Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events
    Review

    Gu, S. L.; Nath, S.; Markova, A.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Management of immune-related cutaneous adverse events with dupilumab
    Journal Article

    Kuo, A. M. S.; Gu, S.; Stoll, J.; Moy, A. P.; Dusza, S. W.; Gordon, A.; Haliasos, E. C.; Janjigian, Y.; Kraehenbuehl, L.; Quigley, E. A.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of refractory lenalidomide rash in patients with multiple myeloma
    Research Letter

    Kuo, A. M.; Hassoun, H.; Shah, U.; Gordon, A.; Hollmann, T. J.; Landau, H. J.; Lezcano, C.; Mailankody, S.; Tan, C. C.; Lesokhin, A. M.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save